Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
No longer listed with the IRS — appears terminated
This organization is no longer in the IRS Exempt Organizations Master File or Pub 78 — its most recent Form 990 (FY2024) appears to be a final return (dissolved or merged). It is not currently a verifiable tax-exempt organization; the information below is historical.
EIN 81-4940010 · Snapshot of IRS recognition, filing currency, financial health, and governance.
The mission of the foundation is to raise funds and foster basic and translational research to identify genetic causes of specific cancers, understand how genes contribute to the disease, and use that understanding to help develop better prevention and treatment strategies. We strongly believe that by using genomic approaches as well as Immunotherapy, we will be able to not only promote early diagnosis and prevention, but also develop cutting edge technologies to successfully fight cancer.
Total Revenue
$0
FY2024
Total Expenses
$7K
FY2024
Net Assets
$0
Program Ratio
75.9%
expenses on programs
Employees
0
Volunteers
0
Board Members
2
Voting
1
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.